Cell Impact (STU:ICL) Other Current Liabilities: €0.80 Mil (As of Mar. 2026)


What is Cell Impact Other Current Liabilities?

Cell Impact STU:ICL Other Current Liabilities is €0.80 Mil as of Mar. 2026. The stock has 7 warning signs investors should review.

Cell Impact's other current liabilities for the quarter that ended in Mar. 2026 was €0.80 Mil.

Cell Impact's quarterly other current liabilities increased from Sep. 2025 (€0.59 Mil) to Dec. 2025 (€1.04 Mil) but then declined from Dec. 2025 (€1.04 Mil) to Mar. 2026 (€0.80 Mil).

Cell Impact's annual other current liabilities declined from Dec. 2023 (€2.37 Mil) to Dec. 2024 (€0.84 Mil) but then increased from Dec. 2024 (€0.84 Mil) to Dec. 2025 (€1.04 Mil).

Cell Impact Other Current Liabilities Related Terms

Cell Impact Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Cell Impact's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact Other Current Liabilities Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.99 1.74 2.37 0.84 1.04

Cell Impact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.79 0.59 1.04 0.80

Cell Impact Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €0.80 Mil mean?
Cell Impact (STU:ICL) has a Other Current Liabilities of €0.80 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cell Impact.
Is Cell Impact's Other Current Liabilities too high?
Cell Impact's current Other Current Liabilities is €0.80 Mil.
How does Cell Impact's Other Current Liabilities compare to CRS and ATI?
Cell Impact's Other Current Liabilities of €0.80 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for an Industrial Products company?
A good Other Current Liabilities depends on the Industrial Products industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cell Impact. Cell Impact's current Other Current Liabilities is €0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (STU:ICL) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.00 — trading 88% below its estimated fair value. The current Other Current Liabilities is €0.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Cell Impact (STU:ICL), the current Other Current Liabilities is €0.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges CI:SwedenICL:Germany
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.